markets: Hemang Jani’s top stock bet from pharma sector
“The fact bond yields went down when you had that big dividend payout, I think there was a bit of an outperformance. So, I think you could look for some …
“The fact bond yields went down when you had that big dividend payout, I think there was a bit of an outperformance. So, I think you could look for some …
“I think there is a growth in terms of volume, given the kind of appetite that people have for jewellery and also, we feel that you will see stable margins …
“There might be some psychological or emotional reaction in a shorter term, saying government would not be able to carry out this reform, that reform, but I do not think …
“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus …
The Indian market is expected to consolidate on Wednesday tracking muted global cues. The S&P BSE Sensex fell more than 300 points while the Nifty50 closed below 21,700 levels on …